417 related articles for article (PubMed ID: 20015182)
1. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
[TBL] [Abstract][Full Text] [Related]
2. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
3. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
Malla N; Kaul P; Sehgal R; Gupta I
Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
[TBL] [Abstract][Full Text] [Related]
4. Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes.
Hrdý I; Cammack R; Stopka P; Kulda J; Tachezy J
Antimicrob Agents Chemother; 2005 Dec; 49(12):5033-6. PubMed ID: 16304169
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
[TBL] [Abstract][Full Text] [Related]
6. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
Butler SE; Augostini P; Secor WE
Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea.
Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P
Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203
[TBL] [Abstract][Full Text] [Related]
8. Use of Trichomonas vaginalis clinical isolates to evaluate correlation of gene expression and metronidazole resistance.
Mead JR; Fernadez M; Romagnoli PA; Secor WE
J Parasitol; 2006 Feb; 92(1):196-9. PubMed ID: 16629339
[TBL] [Abstract][Full Text] [Related]
9. Trichomonads, hydrogenosomes and drug resistance.
Kulda J
Int J Parasitol; 1999 Feb; 29(2):199-212. PubMed ID: 10221623
[TBL] [Abstract][Full Text] [Related]
10. The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
Leitsch D; Kolarich D; Duchêne M
Mol Biochem Parasitol; 2010 May; 171(1):17-24. PubMed ID: 20093143
[TBL] [Abstract][Full Text] [Related]
11. The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.
Dunn LA; Andrews KT; McCarthy JS; Wright JM; Skinner-Adams TS; Upcroft P; Upcroft JA
Int J Antimicrob Agents; 2007 Jan; 29(1):98-102. PubMed ID: 17137752
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro sensitivity to metronidazole of Trichomonas vaginalis with isolates and clones.
Sithithaworn P; Sithithaworn J; Kitjaroen K; Pairojkul C; Ratananurakpong S; Sriswangwonk T
Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):279-84. PubMed ID: 2609217
[TBL] [Abstract][Full Text] [Related]
14. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T
Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural alterations induced by Δ(24(25))-sterol methyltransferase inhibitors on Trichomonas vaginalis.
Rosa Ide A; Rocha DA; de Souza W; Urbina JA; Benchimol M
FEMS Microbiol Lett; 2011 Feb; 315(1):72-8. PubMed ID: 21175744
[TBL] [Abstract][Full Text] [Related]
16. Biological variability of Trichomonas vaginalis clinical isolates from symptomatic and asymptomatic patients.
Hussien EM; El-Sayed HZ; Shaban MM; Salm AM; Rashwan M
J Egypt Soc Parasitol; 2004 Dec; 34(3):979-88. PubMed ID: 15587322
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
18. [Mycoplasma hominis symbiosis and Trichomonas vaginalis metronidazole resistance].
Wang PJ; Xie CB
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Jun; 30(3):210-3. PubMed ID: 23072138
[TBL] [Abstract][Full Text] [Related]
19. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates.
Goodhew EB; Secor WE
Sex Transm Infect; 2013 Sep; 89(6):479-84. PubMed ID: 23794105
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.
Wright JM; Dunn LA; Kazimierczuk Z; Burgess AG; Krauer KG; Upcroft P; Upcroft JA
Parasitol Res; 2010 Sep; 107(4):847-53. PubMed ID: 20532912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]